Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-29

Clinical Trial Update: Study of Telbivudine in Chronic Hepatitis B

View source ↗

Summary

Clinical trial studying telbivudine for chronic hepatitis B has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telbivudine (telbivudine)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Chronic Hepatitis B | Status: COMPLETED | Results posted: 2016-02-29